TEVA logo

TEVA Cash From Operations

Annual CFO:

$2.54B-$307.00M(-10.79%)
December 31, 2024

Summary

  • As of today, TEVA annual cash from operations is $2.54 billion, with the most recent change of -$307.00 million (-10.79%) on December 31, 2024.
  • During the last 3 years, TEVA annual cash from operations has risen by +$92.00 million (+3.76%).
  • TEVA annual cash from operations is now -54.20% below its all-time high of $5.54 billion, reached on December 31, 2015.

Performance

TEVA Cash From Operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTEVAcash flow metrics

Quarterly CFO:

-$474.01M-$691.01M(-318.44%)
June 30, 2025

Summary

  • As of today, TEVA quarterly cash from operations is -$474.01 million, with the most recent change of -$691.01 million (-318.44%) on June 30, 2025.
  • Over the past year, TEVA quarterly cash from operations has dropped by -$894.01 million (-212.86%).
  • TEVA quarterly cash from operations is now -122.14% below its all-time high of $2.14 billion, reached on December 31, 2017.

Performance

TEVA Quarterly Cash From Operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTEVAcash flow metrics

TTM CFO:

$1.69B-$894.01M(-34.60%)
June 30, 2025

Summary

  • As of today, TEVA TTM cash from operations is $1.69 billion, with the most recent change of -$894.01 million (-34.60%) on June 30, 2025.
  • Over the past year, TEVA TTM cash from operations has dropped by -$873.01 million (-34.06%).
  • TEVA TTM cash from operations is now -71.88% below its all-time high of $6.01 billion, reached on June 30, 2015.

Performance

TEVA TTM Cash From Operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTEVAcash flow metrics

Cash From Operations Formula

CFO = Net Income + Non Cash Expenses + Changes In Working Capital

TEVA Cash From Operations Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year-10.8%-212.9%-34.1%
3Y3 Years+3.8%-215.6%-30.1%
5Y5 Years+13.6%-170.3%-41.8%

TEVA Cash From Operations Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Year-10.8%+3.8%-129.5%at low-47.6%at low
5Y5-Year-10.8%+13.6%-129.5%at low-47.6%at low
All-TimeAll-Time-54.2%>+9999.0%-122.1%+13.7%-71.9%+1843.1%

TEVA Cash From Operations History

DateAnnualQuarterlyTTM
Jun 2025
-
-$474.01M(-318.4%)
$1.69B(-34.6%)
Mar 2025
-
$217.00M(-76.3%)
$2.58B(+1.8%)
Dec 2024
$2.54B(-10.8%)
$915.00M(-11.3%)
$2.54B(-21.4%)
Sep 2024
-
$1.03B(+145.7%)
$3.23B(+25.9%)
Jun 2024
-
$420.00M(+145.6%)
$2.56B(-9.7%)
Mar 2024
-
$171.00M(-89.3%)
$2.84B(-0.2%)
Dec 2023
$2.85B(+4.2%)
$1.60B(+337.3%)
$2.85B(+13.8%)
Sep 2023
-
$367.00M(-47.2%)
$2.50B(-14.9%)
Jun 2023
-
$695.00M(+290.4%)
$2.94B(+10.7%)
Mar 2023
-
$178.00M(-85.9%)
$2.65B(-2.9%)
Dec 2022
$2.73B(+11.6%)
$1.26B(+56.4%)
$2.73B(+18.9%)
Sep 2022
-
$805.00M(+96.3%)
$2.30B(-5.0%)
Jun 2022
-
$410.00M(+60.2%)
$2.42B(-8.1%)
Mar 2022
-
$256.00M(-69.0%)
$2.63B(+7.6%)
Dec 2021
$2.45B(-6.7%)
$826.00M(-10.8%)
$2.45B(+8.5%)
Sep 2021
-
$926.00M(+48.6%)
$2.25B(+14.5%)
Jun 2021
-
$623.00M(+777.5%)
$1.97B(-2.5%)
Mar 2021
-
$71.00M(-88.8%)
$2.02B(-23.0%)
Dec 2020
$2.62B(+17.3%)
$634.00M(-0.9%)
$2.62B(-9.7%)
Sep 2020
-
$640.00M(-5.0%)
$2.90B(-1.6%)
Jun 2020
-
$674.00M(+0.1%)
$2.95B(+21.2%)
Mar 2020
-
$673.00M(-26.6%)
$2.43B(+8.9%)
Dec 2019
$2.23B(-46.5%)
$917.00M(+33.5%)
$2.23B(-34.6%)
Sep 2019
-
$687.00M(+337.6%)
$3.42B(+56.6%)
Jun 2019
-
$157.00M(-66.9%)
$2.18B(-30.9%)
Mar 2019
-
$474.00M(-77.5%)
$3.16B(-24.4%)
Dec 2018
$4.18B(+19.2%)
$2.10B(+482.9%)
$4.18B(-0.9%)
Sep 2018
-
-$549.00M(-148.5%)
$4.22B(-24.2%)
Jun 2018
-
$1.13B(-24.3%)
$5.56B(+14.3%)
Mar 2018
-
$1.50B(-30.1%)
$4.87B(+38.8%)
Dec 2017
$3.51B(-33.1%)
$2.14B(+169.3%)
$3.51B(+25.7%)
Sep 2017
-
$795.00M(+82.8%)
$2.79B(-19.3%)
Jun 2017
-
$435.00M(+219.9%)
$3.46B(-13.2%)
Mar 2017
-
$136.00M(-90.5%)
$3.98B(-23.7%)
Dec 2016
$5.24B(-5.4%)
$1.43B(-2.5%)
$5.22B(-3.5%)
Sep 2016
-
$1.46B(+51.7%)
$5.42B(+7.3%)
Jun 2016
-
$963.00M(-30.0%)
$5.05B(-9.3%)
Mar 2016
-
$1.38B(-14.8%)
$5.56B(+0.4%)
Dec 2015
$5.54B(+8.1%)
$1.61B(+47.8%)
$5.54B(-2.4%)
Sep 2015
-
$1.09B(-26.1%)
$5.68B(-5.5%)
Jun 2015
-
$1.48B(+9.3%)
$6.01B(+7.6%)
Mar 2015
-
$1.35B(-22.7%)
$5.58B(+8.9%)
Dec 2014
$5.13B(+58.4%)
$1.75B(+23.0%)
$5.13B(+23.2%)
Sep 2014
-
$1.42B(+35.2%)
$4.16B(+32.3%)
Jun 2014
-
$1.05B(+17.3%)
$3.15B(+5.0%)
Mar 2014
-
$898.00M(+14.0%)
$3.00B(-7.4%)
Dec 2013
$3.24B(-29.0%)
$788.01M(+93.1%)
$3.24B(-19.7%)
Sep 2013
-
$408.14M(-54.8%)
$4.03B(-14.0%)
Jun 2013
-
$903.78M(-20.4%)
$4.69B(-5.7%)
Mar 2013
-
$1.14B(-28.2%)
$4.97B(+9.1%)
Dec 2012
$4.56B
$1.58B(+48.7%)
$4.56B(+3.9%)
Sep 2012
-
$1.06B(-10.2%)
$4.38B(+16.5%)
DateAnnualQuarterlyTTM
Jun 2012
-
$1.19B(+64.0%)
$3.76B(-3.9%)
Mar 2012
-
$722.95M(-48.7%)
$3.91B(-4.8%)
Dec 2011
$4.11B(-0.4%)
$1.41B(+217.9%)
$4.11B(+8.1%)
Sep 2011
-
$443.42M(-66.9%)
$3.80B(-16.2%)
Jun 2011
-
$1.34B(+45.4%)
$4.54B(+9.0%)
Mar 2011
-
$919.91M(-16.6%)
$4.16B(+0.8%)
Dec 2010
$4.13B(+22.7%)
$1.10B(-6.5%)
$4.13B(+2.6%)
Sep 2010
-
$1.18B(+22.5%)
$4.02B(+5.4%)
Jun 2010
-
$962.47M(+8.7%)
$3.82B(+9.1%)
Mar 2010
-
$885.29M(-11.2%)
$3.50B(+4.1%)
Dec 2009
$3.37B(+4.7%)
$996.67M(+2.4%)
$3.36B(+0.1%)
Sep 2009
-
$973.40M(+50.8%)
$3.36B(+9.1%)
Jun 2009
-
$645.54M(-13.6%)
$3.08B(-4.4%)
Mar 2009
-
$746.83M(-24.8%)
$3.22B(+0.2%)
Dec 2008
$3.21B(+78.4%)
$992.93M(+43.2%)
$3.21B(+16.7%)
Sep 2008
-
$693.19M(-11.9%)
$2.75B(+15.8%)
Jun 2008
-
$786.58M(+6.1%)
$2.38B(+16.2%)
Mar 2008
-
$741.25M(+39.2%)
$2.05B(+13.5%)
Dec 2007
$1.80B(-12.0%)
$532.60M(+67.5%)
$1.80B(-10.9%)
Sep 2007
-
$318.04M(-30.1%)
$2.02B(-19.0%)
Jun 2007
-
$454.93M(-8.7%)
$2.50B(+10.8%)
Mar 2007
-
$498.20M(-33.8%)
$2.26B(+10.2%)
Dec 2006
$2.05B(+49.2%)
$753.06M(-5.2%)
$2.05B(+31.7%)
Sep 2006
-
$794.28M(+275.7%)
$1.55B(+36.2%)
Jun 2006
-
$211.44M(-26.8%)
$1.14B(-15.7%)
Mar 2006
-
$288.98M(+11.1%)
$1.35B(-1.5%)
Dec 2005
$1.37B(+9.9%)
$260.01M(-31.7%)
$1.37B(-8.5%)
Sep 2005
-
$380.71M(-10.1%)
$1.50B(-0.9%)
Jun 2005
-
$423.27M(+37.0%)
$1.51B(+13.4%)
Mar 2005
-
$308.92M(-20.2%)
$1.34B(+6.9%)
Dec 2004
$1.25B(+100.5%)
$386.95M(-1.9%)
$1.25B(+19.5%)
Sep 2004
-
$394.49M(+61.2%)
$1.05B(+60.6%)
Jun 2004
-
$244.76M(+9.7%)
$651.11M(+60.2%)
Mar 2004
-
$223.20M(+21.9%)
$406.35M(+121.9%)
Dec 2003
$623.10M(+75.8%)
$183.15M(+54.7%)
$183.15M(-45.8%)
Dec 2002
$354.36M(+29.7%)
-
-
Jun 2002
-
$118.42M(+15.0%)
$337.89M(+16.8%)
Mar 2002
-
$103.00M(+104.6%)
$289.18M(+5.9%)
Dec 2001
$273.15M(+64.9%)
$50.35M(-23.8%)
$273.15M(+22.6%)
Sep 2001
-
$66.12M(-5.2%)
$222.80M(+42.2%)
Jun 2001
-
$69.71M(-19.8%)
$156.68M(+80.2%)
Mar 2001
-
$86.97M
$86.97M
Dec 2000
$165.63M(-74.0%)
-
-
Dec 1999
$637.82M(+139.3%)
-
-
Dec 1998
$266.54M(+37.3%)
-
-
Dec 1997
$194.18M(+2936.2%)
-
-
Dec 1996
-$6.85M(-106.2%)
-
-
Dec 1995
$110.22M(+188.2%)
-
-
Dec 1994
$38.25M(-4.0%)
-
-
Dec 1993
$39.85M(+28.8%)
-
-
Dec 1992
$30.94M(+240.0%)
-
-
Dec 1991
$9.10M
-
-

FAQ

  • What is Teva Pharmaceutical Industries Limited annual cash from operations?
  • What is the all-time high annual cash from operations for Teva Pharmaceutical Industries Limited?
  • What is Teva Pharmaceutical Industries Limited annual cash from operations year-on-year change?
  • What is Teva Pharmaceutical Industries Limited quarterly cash from operations?
  • What is the all-time high quarterly cash from operations for Teva Pharmaceutical Industries Limited?
  • What is Teva Pharmaceutical Industries Limited quarterly cash from operations year-on-year change?
  • What is Teva Pharmaceutical Industries Limited TTM cash from operations?
  • What is the all-time high TTM cash from operations for Teva Pharmaceutical Industries Limited?
  • What is Teva Pharmaceutical Industries Limited TTM cash from operations year-on-year change?

What is Teva Pharmaceutical Industries Limited annual cash from operations?

The current annual cash from operations of TEVA is $2.54B

What is the all-time high annual cash from operations for Teva Pharmaceutical Industries Limited?

Teva Pharmaceutical Industries Limited all-time high annual cash from operations is $5.54B

What is Teva Pharmaceutical Industries Limited annual cash from operations year-on-year change?

Over the past year, TEVA annual cash from operations has changed by -$307.00M (-10.79%)

What is Teva Pharmaceutical Industries Limited quarterly cash from operations?

The current quarterly cash from operations of TEVA is -$474.01M

What is the all-time high quarterly cash from operations for Teva Pharmaceutical Industries Limited?

Teva Pharmaceutical Industries Limited all-time high quarterly cash from operations is $2.14B

What is Teva Pharmaceutical Industries Limited quarterly cash from operations year-on-year change?

Over the past year, TEVA quarterly cash from operations has changed by -$894.01M (-212.86%)

What is Teva Pharmaceutical Industries Limited TTM cash from operations?

The current TTM cash from operations of TEVA is $1.69B

What is the all-time high TTM cash from operations for Teva Pharmaceutical Industries Limited?

Teva Pharmaceutical Industries Limited all-time high TTM cash from operations is $6.01B

What is Teva Pharmaceutical Industries Limited TTM cash from operations year-on-year change?

Over the past year, TEVA TTM cash from operations has changed by -$873.01M (-34.06%)
On this page